Safety and Efficacy Results of Retreatment With a PARP Inhibitor Monotherapy in Late-Line Recurrent Ovarian Cancer: Results From a Subset of the QUADRA Trial

Overview of attention for article published in Gynecologic Oncology, March 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 1 X post from an account with 3 followers.

Check this later. https://t.co/Ci27V3ycMx

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.

Login to access the Sentiment Analysis related to this output.